CN104905271A - Health-care astaxanthin capsule with blood lipid regulating effect - Google Patents
Health-care astaxanthin capsule with blood lipid regulating effect Download PDFInfo
- Publication number
- CN104905271A CN104905271A CN201510347260.0A CN201510347260A CN104905271A CN 104905271 A CN104905271 A CN 104905271A CN 201510347260 A CN201510347260 A CN 201510347260A CN 104905271 A CN104905271 A CN 104905271A
- Authority
- CN
- China
- Prior art keywords
- parts
- capsule
- astaxanthin
- raw material
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 52
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 46
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 46
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 46
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 46
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 46
- 239000008280 blood Substances 0.000 title claims abstract description 31
- 210000004369 blood Anatomy 0.000 title claims abstract description 31
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 22
- 150000002632 lipids Chemical class 0.000 title abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 29
- 241000411851 herbal medicine Species 0.000 claims abstract description 18
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 241000132012 Atractylodes Species 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 8
- 241000005787 Cistanche Species 0.000 claims abstract description 8
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 8
- 241000050051 Chelone glabra Species 0.000 claims description 7
- 241000830535 Ligustrum lucidum Species 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 7
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 7
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000004575 stone Substances 0.000 claims description 7
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 5
- 241000607479 Yersinia pestis Species 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000008361 herbal raw material Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract 2
- 229920001661 Chitosan Polymers 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000007674 genetic toxicity Effects 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health-care astaxanthin capsule with a blood lipid regulating effect. The capsule is prepared by scientific compatibility of chitosan and Chinese herbal medicines, preferably 30-40 parts of astaxanthin, 15-20 parts of radix bupleuri, 15-18 parts of fructus lycii, 10-14 parts of radix scutellariae, 8-10 parts of stevia, 8-10 parts of liquorice, 6-10 parts of fructus ligustri lucidi, 4-8 parts of largehead atractylodes rhizome, 5-8 parts of rhizoma polygoni cuspidate, 4-6 parts of herba cistanches, 4-6 parts of cassia seeds,4-6 parts of herba artemisiae scopariae, 3-5 parts of semen astragali complanati and 2-3 parts of maifanitum, and is prepared by the processes of blending, mixing, sterilizing and filling the capsule. The capsule has the effects of regulating the blood lipid, tonifying qi, benefiting, enhancing the immunity, resisting fatigue, and prolonging the life and the like through the synergistic effect of astaxanthin and the Chinese herbal medicines, is safe, has no side effect, is convenient to eat, and has good market application prospect.
Description
Technical field
The present invention relates to a kind of astaxanthin health-caring capsule with effect of regulating blood fat, particularly a kind of health-caring capsule made for raw material with astaxanthin and vegetable Chinese herbal medicine, belong to field of health care food.
Technical background
Astaxanthin (astaxanthin), also known as " ASX ", is a kind of Red carotenoids found from shrimp crab shell, oyster, salmon and algae, fungi.There are some researches show in recent years, natural astaxanthin has stronger antioxidation activity, has scavenging free radicals, protection blood vessel, reduction cholesterol, skin care, vision protection, neuroprotective system, prevention senile dementia, alleviates many-sided nutrition health-care functions such as arthralgia; Particularly natural astaxanthin has strong antioxidation activity, is called as " supper vitamin E ", " super antioxidant ".A large amount of human trial of natural astaxanthin and animal experiment verified it be a kind of very safe carotenoid.In Japan, natural astaxanthin also for food and animal feed, U.S. FDA, European Union, Canadian food surveillance office also approved it as the feed addictive of salmon class.Because it has multiple biological effect, the application in nutrition and medicine has vast potential for future development, and particularly astaxanthin has boundless application prospect as the high-class healthy food of the mankind.
Along with improving constantly of people's living standard, people with hyperlipidemia increases increasingly, become and affect one of healthy maximum hidden danger of the our people masses, at present high fat of blood and the complication that caused by high fat of blood are taked more to the mode of drug therapy, often there is larger side effect, and not easily effect a radical cure.Chinese herbal medicine is the rarity of Chinese traditional culture, has the advantage that drug therapy is incomparable in dietotherapy, in conjunction with the medicinal health care function of China's traditional medicine, develops the health-caring capsule with effect of regulating blood fat and benefits the nation and the people, have great importance.
At present, also there is more drawback in the application of Chinese herbal medicine in field of health care food, is difficult to the health-care efficacy really playing Chinese herbal medicine.The present invention is directed to the problems referred to above, develop a kind of health-caring capsule with effect of regulating blood fat utilizing astaxanthin and composite Chinese herbal, meet the demand of market to astaxanthin and herbal health care food.
Summary of the invention
For overcoming the deficiencies in the prior art, the object of the present invention is to provide a kind of astaxanthin health-caring capsule with effect of regulating blood fat, the effects such as this health-caring capsule has adjusting blood lipid, develop immunitypty, antifatigue, promote longevity, meet increasing diabetic to efficient, safety, harmless adjusting blood lipid health products demand.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
The invention provides a kind of astaxanthin health-caring capsule with effect of regulating blood fat, it is characterized in that health-caring capsule raw material composition and quality proportioning are: astaxanthin 30 ~ 40 parts, radix bupleuri 15 ~ 20 parts, matrimony vine 15 ~ 18 parts, the root of large-flowered skullcap 10 ~ 14 parts, STEVIA REBAUDIANA 8 ~ 10 parts, 8 ~ 10 parts, Radix Glycyrrhizae, the fruit of glossy privet 6 ~ 10 parts, the bighead atractylodes rhizome 4 ~ 8 parts, giant knotweed 5 ~ 8 parts, saline cistanche 4 ~ 6 parts, cassia seed 4 ~ 6 parts, Radix Angelicae Sinensis 4 ~ 6 parts, semen astragali complanati 3 ~ 5 parts, medical stone 2 ~ 3 parts.
The preferred technical solution of the present invention is: a kind of astaxanthin health-caring capsule with effect of regulating blood fat, is characterized in that: it is characterized in that health-caring capsule raw material composition and quality proportioning are: astaxanthin 35 parts, radix bupleuri 18 parts, matrimony vine 16 parts, the root of large-flowered skullcap 12 parts, STEVIA REBAUDIANA 9 parts, 9 parts, Radix Glycyrrhizae, the fruit of glossy privet 8 parts, the bighead atractylodes rhizome 6 parts, giant knotweed 6 parts, saline cistanche 5 parts, cassia seed 5 parts, Radix Angelicae Sinensis 5 parts, semen astragali complanati 4 parts, medical stone 2.5 parts.
The invention provides a kind of astaxanthin health-caring capsule with effect of regulating blood fat, it is characterized in that being prepared by following steps:
(1) pretreatment of raw material: sorted by Chinese herbal medicine used, removes impurity, goes mouldy and has the raw material etc. of disease and pest;
(2) dry: raw material is dried to constant weight respectively in microwave vacuum dryer;
(3) pulverize: respectively astaxanthin and herbal raw material superminiature pulverizer are pulverized, cross 2000 mesh sieves;
(4) allotment is weighed: allocated according to aforementioned proportion by the raw material after pulverizing;
(5) mix: deployed raw material mixed at high speed mixer is fully mixed;
(6) sterilizing: with cobalt-60 sterilizing;
(7) filling capsule: filling at indoor No. 0 capsule of cleaning;
(8) shaped article: bottled by the capsule after filling, labeling, namely coding obtains the astaxanthin health-caring capsule with effect of regulating blood fat.
The invention provides a kind of astaxanthin health-caring capsule with effect of regulating blood fat, carried out toxicology test and the safety evaluatio of health-caring capsule by animal experiment.Chmice acute Oral toxicity result of the test shows, this health-caring capsule is greater than high dose group 75mg/kgbw to chmice acute per os maximum tolerated dose; Genetic toxicity test mouse marrow cell micro nuclear test and mouse inbred strain two result of the tests are feminine gender, show that this health-caring capsule is without mutagenesis; From rat 30d feeding trial, the behavior of rat sign is normal, figure is healthy, blood and blood parameters also change without exception, and therefore the dosage (150 times of human body recommended amounts) of 75mg/kgbw belongs to safe dose; Genetic toxicity test and rat 30d feeding trial result are feminine gender, therefore determine that this health-caring capsule belongs to non-toxic type food, and people can be safe relieved edible.
The invention provides a kind of astaxanthin health-caring capsule with effect of regulating blood fat, it is advantageous that scientific compatibility astaxanthin and multiple Chinese herbal medicine, can effectively adjusting blood lipid, develop immunitypty, antifatigue, the effect such as to promote longevity by the synergy between astaxanthin and Chinese herbal medicine, safety has no side effect, instant.Different Chinese herbal medicine nature and flavor are different, effect also exists huge difference, complicated interaction relationship is there is after different Chinese herbal medicine combinations, and proportioning between Chinese herbal medicine is closer, different ratio also will make monarch relation that substantial change occurs, thus make the relation generation material alterations of composite Chinese herbal.Complicated interaction relationship is there is to each other in the application by Chinese herbal medicines such as astaxanthin and matrimony vine, radix bupleuri, the root of large-flowered skullcap, STEVIA REBAUDIANA, Radix Glycyrrhizae, the fruit of glossy privet, the bighead atractylodes rhizome, giant knotweed, saline cistanche, cassia seed, Radix Angelicae Sinensis, semen astragali complanati, medical stones, rational proportion, achieve unforeseeable technique effect, make the relation generation material alterations of health-caring capsule.Utilize rat experiment to measure the indexs such as TC, TG, HDL-C, the modeling test group of this capsule after three weeks of feeding lipids contents compared with control group declines 24.86%, illustrates that product has good adjusting blood lipid active; And result of the test shows that change health-caring capsule raw material composition or proportioning can reduce the adjusting blood lipid ability (P<0.01) of health-caring capsule, illustrates that the synergy between astaxanthin and Chinese herbal medicine serves the effect significantly promoting health-caring capsule functional activity.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1:
There is an astaxanthin health-caring capsule for effect of regulating blood fat, prepared by following steps:
(1) pretreatment of raw material: sorted by Chinese herbal medicine used, removes impurity, goes mouldy and has the raw material etc. of disease and pest;
(2) dry: raw material is dried to constant weight respectively in microwave vacuum dryer;
(3) pulverize: respectively astaxanthin and herbal raw material superminiature pulverizer are pulverized, cross 2000 mesh sieves;
(4) allotment is weighed: allocated according to astaxanthin 35 parts, radix bupleuri 18 parts, matrimony vine 16 parts, the root of large-flowered skullcap 12 parts, STEVIA REBAUDIANA 9 parts, 9 parts, Radix Glycyrrhizae, the fruit of glossy privet 8 parts, the bighead atractylodes rhizome 6 parts, giant knotweed 6 parts, saline cistanche 5 parts, cassia seed 5 parts, Radix Angelicae Sinensis 5 parts, semen astragali complanati 4 parts, medical stone 2.5 parts of ratios by the raw material after pulverizing;
(5) mix: deployed raw material mixed at high speed mixer is fully mixed;
(6) sterilizing: with cobalt-60 sterilizing;
(7) filling capsule: filling at indoor No. 0 capsule of cleaning;
(8) shaped article: bottled by the capsule after filling, labeling, namely coding obtains the astaxanthin health-caring capsule with effect of regulating blood fat.
Embodiment 2:
There is an astaxanthin health-caring capsule for effect of regulating blood fat, prepared by following steps:
(1) pretreatment of raw material: sorted by Chinese herbal medicine used, removes impurity, goes mouldy and has the raw material etc. of disease and pest;
(2) dry: raw material is dried to constant weight respectively in microwave vacuum dryer;
(3) pulverize: respectively astaxanthin and herbal raw material superminiature pulverizer are pulverized, cross 2000 mesh sieves;
(4) allotment is weighed: allocated according to astaxanthin 40 parts, radix bupleuri 15 parts, matrimony vine 18 parts, the root of large-flowered skullcap 10 parts, STEVIA REBAUDIANA 10 parts, 8 parts, Radix Glycyrrhizae, the fruit of glossy privet 10 parts, the bighead atractylodes rhizome 4 parts, giant knotweed 8 parts, saline cistanche 4 parts, cassia seed 6 parts, Radix Angelicae Sinensis 4 parts, semen astragali complanati 5 parts, medical stone 2 parts of ratios by the raw material after pulverizing;
(5) mix: deployed raw material mixed at high speed mixer is fully mixed;
(6) sterilizing: with cobalt-60 sterilizing;
(7) filling capsule: filling at indoor No. 0 capsule of cleaning;
(8) shaped article: bottled by the capsule after filling, labeling, namely coding obtains the astaxanthin health-caring capsule with effect of regulating blood fat.
Embodiment 3:
There is an astaxanthin health-caring capsule for effect of regulating blood fat, prepared by following steps:
(1) pretreatment of raw material: sorted by Chinese herbal medicine used, removes impurity, goes mouldy and has the raw material etc. of disease and pest;
(2) dry: raw material is dried to constant weight respectively in microwave vacuum dryer;
(3) pulverize: respectively astaxanthin and herbal raw material superminiature pulverizer are pulverized, cross 2000 mesh sieves;
(4) allotment is weighed: allocated according to astaxanthin 30 parts, radix bupleuri 20 parts, matrimony vine 15 parts, the root of large-flowered skullcap 14 parts, STEVIA REBAUDIANA 8 parts, 10 parts, Radix Glycyrrhizae, the fruit of glossy privet 6 parts, the bighead atractylodes rhizome 8 parts, giant knotweed 5 parts, saline cistanche 6 parts, cassia seed 4 parts, Radix Angelicae Sinensis 6 parts, semen astragali complanati 3 parts, medical stone 3 parts of ratios by the raw material after pulverizing;
(5) mix: deployed raw material mixed at high speed mixer is fully mixed;
(6) sterilizing: with cobalt-60 sterilizing;
(7) filling capsule: filling at indoor No. 0 capsule of cleaning;
(8) shaped article: bottled by the capsule after filling, labeling, namely coding obtains the astaxanthin health-caring capsule with effect of regulating blood fat.
Above embodiment only for illustration of technical scheme of the present invention, but not is limited; Although be described in detail by invention with reference to previous embodiment, for the person of ordinary skill of the art, still the technical scheme described in previous embodiment can be modified, or equivalent replacement has been carried out to wherein portion of techniques feature; And to these amendments or replacement, do not make the essence of appropriate technical solution depart from the spirit and scope of the present invention's technical scheme required for protection.
Claims (1)
1. there is an astaxanthin health-caring capsule for effect of regulating blood fat, it is characterized in that being prepared by following steps:
(1) pretreatment of raw material: sorted by Chinese herbal medicine used, removes impurity, goes mouldy and has the raw material etc. of disease and pest;
(2) dry: raw material is dried to constant weight respectively in microwave vacuum dryer;
(3) pulverize: respectively astaxanthin and herbal raw material superminiature pulverizer are pulverized, cross 2000 mesh sieves;
(4) allotment is weighed: allocated according to astaxanthin 30 ~ 40 parts, radix bupleuri 15 ~ 20 parts, matrimony vine 15 ~ 18 parts, the root of large-flowered skullcap 10 ~ 14 parts, STEVIA REBAUDIANA 8 ~ 10 parts, 8 ~ 10 parts, Radix Glycyrrhizae, the fruit of glossy privet 6 ~ 10 parts, the bighead atractylodes rhizome 4 ~ 8 parts, giant knotweed 5 ~ 8 parts, saline cistanche 4 ~ 6 parts, cassia seed 4 ~ 6 parts, old 4 ~ 6 parts of bacterium, semen astragali complanati 3 ~ 5 parts, medical stone 2 ~ 3 parts of ratios by the raw material after pulverizing;
(5) mix: deployed raw material mixed at high speed mixer is fully mixed;
(6) sterilizing: with cobalt-60 sterilizing;
(7) filling capsule: filling at indoor No. 0 capsule of cleaning;
(8) shaped article: bottled by the capsule after filling, labeling, namely coding obtains the astaxanthin health-caring capsule with effect of regulating blood fat.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510347260.0A CN104905271A (en) | 2015-06-19 | 2015-06-19 | Health-care astaxanthin capsule with blood lipid regulating effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510347260.0A CN104905271A (en) | 2015-06-19 | 2015-06-19 | Health-care astaxanthin capsule with blood lipid regulating effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104905271A true CN104905271A (en) | 2015-09-16 |
Family
ID=54075057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510347260.0A Pending CN104905271A (en) | 2015-06-19 | 2015-06-19 | Health-care astaxanthin capsule with blood lipid regulating effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104905271A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920537A (en) * | 2016-06-23 | 2016-09-07 | 青岛浩大海洋保健食品有限公司 | Euphausia superba oil health capsule capable of reducing blood fat |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885300A (en) * | 2012-09-19 | 2013-01-23 | 无锡市天赐康生物科技有限公司 | Health-care food with blood sugar reducing effect and preparation method thereof |
| CN103815223A (en) * | 2014-01-23 | 2014-05-28 | 山东百龙创园生物科技有限公司 | Nutrition health-care composition containing astaxanthin |
| CN103829234A (en) * | 2013-12-25 | 2014-06-04 | 无锡市天赐康生物科技有限公司 | Health food capable of improving immunity and reducing blood fat and preparation method thereof |
| CN104645077A (en) * | 2013-11-22 | 2015-05-27 | 万光瑞 | Traditional Chinese medicine preparation for preventing and treating ischemic cerebrovascular disease and preparation method of traditional Chinese medicine preparation |
-
2015
- 2015-06-19 CN CN201510347260.0A patent/CN104905271A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885300A (en) * | 2012-09-19 | 2013-01-23 | 无锡市天赐康生物科技有限公司 | Health-care food with blood sugar reducing effect and preparation method thereof |
| CN104645077A (en) * | 2013-11-22 | 2015-05-27 | 万光瑞 | Traditional Chinese medicine preparation for preventing and treating ischemic cerebrovascular disease and preparation method of traditional Chinese medicine preparation |
| CN103829234A (en) * | 2013-12-25 | 2014-06-04 | 无锡市天赐康生物科技有限公司 | Health food capable of improving immunity and reducing blood fat and preparation method thereof |
| CN103815223A (en) * | 2014-01-23 | 2014-05-28 | 山东百龙创园生物科技有限公司 | Nutrition health-care composition containing astaxanthin |
Non-Patent Citations (4)
| Title |
|---|
| 潘卫三: "《工业药剂学（第2版）》", 30 June 2010, 中国医药科技出版社 * |
| 罗仁勇等: "天然虾青素软胶囊降血脂功能的实验研究", 《现代预防医学》 * |
| 胡婷婷等: "响应面法优化虾青素微胶囊制备工艺", 《食品科学》 * |
| 高望宗等: "《冠心病防治宜与忌（第1版）》", 31 December 2011, 兰州大学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920537A (en) * | 2016-06-23 | 2016-09-07 | 青岛浩大海洋保健食品有限公司 | Euphausia superba oil health capsule capable of reducing blood fat |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104621571B (en) | A kind of powerful body-strengthening nutrient health food | |
| CN105639169A (en) | Feed capable of enhancing immunity of chicken | |
| CN105031315A (en) | Ocean health care capsule having efficacy of lowering blood sugar | |
| CN104887740A (en) | Astaxanthin healthcare capsule with immunity regulating efficacy | |
| CN105029608A (en) | Marine functional health beverage with ageing delaying efficacy | |
| CN105054180A (en) | Health-care rose beverage for regulating blood lipid | |
| CN105475589A (en) | Sugar-free shark fin bone meal tablet candy for preventing tumors and improving immunity, and production technology thereof | |
| CN105028925A (en) | Chinese herbal medicine feed nutrient for poultry | |
| CN102895584A (en) | Traditional Chinese medicine preparation for enhancing pig antibiosis and anti-virus, and preparation method thereof | |
| CN104877882A (en) | Astaxanthin composite mixed liquor with blood glucose reducing function | |
| CN104905271A (en) | Health-care astaxanthin capsule with blood lipid regulating effect | |
| CN104984102A (en) | Astaxanthin health care capsule with blood sugar decreasing effect | |
| CN101167977B (en) | Chinese medicinal herb additive for preventing chicken high febrile disease | |
| CN105901722A (en) | Euphausia superba oil healthcare capsule for preventing Alzheimer's disease | |
| CN105920537A (en) | Euphausia superba oil health capsule capable of reducing blood fat | |
| CN105475798A (en) | Shark fin bone meal solid beverage with blood fat lowering efficacy, and preparation technology thereof | |
| CN105029570A (en) | Astaxanthin health beverage with ageing delaying efficacy | |
| CN104921244A (en) | Astaxanthin health beverage with blood lipid regulation function | |
| CN105011277A (en) | Blood lipid regulating marine functional health-care beverage | |
| CN106072546A (en) | A kind of relieving alcoholism and protecting the liver health-caring capsule | |
| CN105559060B (en) | A kind of beneficial spleen stomach invigorating filefish fish oil health-caring capsule | |
| CN104905272A (en) | Health astaxanthin capsule with effect of delaying senility | |
| CN104893931A (en) | Marine functional compound-prepared wine with blood fat regulation effect | |
| CN105031314A (en) | Marine health capsule with blood lipid regulating function | |
| CN104886435A (en) | Chitosan-containing health care capsule with blood lipid regulation efficacy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150916 |